B2M and breast cancer: A humanized mouse model of breast cancer was constructed by transferring HSPC, peripheral T cells from the same donor and breast cancer cell lines into NOD-SCID B2m-/- mice, in which CD4 + T cells were found to promote early tumor development through a DC-dependent pattern and the process could be partially inhibited by antagonists of IL-13 [10].